---
figid: PMC7196244__CMAR-12-2875-g0006
figtitle: An illustration of how EVO exerts anticancer activity in osteosarcoma cells
  through the suppressing Wnt/Beta-catenin signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7196244
filename: CMAR-12-2875-g0006.jpg
figlink: pmc/articles/PMC7196244/figure/F0006/
number: F6
caption: An illustration of how EVO exerts anticancer activity in osteosarcoma cells
  through the suppressing Wnt/β-catenin signaling pathway.
papertitle: Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through
  the Wnt/β-Catenin Signaling Pathway.
reftext: Shengdong Yang, et al. Cancer Manag Res. 2020;12:2875-2888.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.899782
figid_alias: PMC7196244__F6
figtype: Figure
redirect_from: /figures/PMC7196244__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7196244__CMAR-12-2875-g0006.html
  '@type': Dataset
  description: An illustration of how EVO exerts anticancer activity in osteosarcoma
    cells through the suppressing Wnt/β-catenin signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDH1
  - FZR1
  - GSK3B
  - CTNNB1
  - CDH2
  - APC
  - PROC
  - BCL2
  - AXIN1
  - AXIN2
  - MYC
  - HNF4A
---
